in-PharmaTechnologist Podcast

Almac invests in biocatalysis lauding cost and environmental benefits


Listen Later

Almac invests $4m in biocatalysis R&D, describing such technologies as the way forward for the cost efficient production of highly chiral APIs and intermediates.
...more
View all episodesView all episodes
Download on the App Store

in-PharmaTechnologist PodcastBy William Reed Business Media